{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:27:39Z","timestamp":1794652059441,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-116387"],"award-info":[{"award-number":["HL-116387"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-04726"],"award-info":[{"award-number":["HL-04726"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001078","name":"Diabetes Research Institute Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Obesity and adipose tissue expansion is characterized by a chronic state of systemic inflammation that contributes to disease. The neuropeptide, oxytocin, working through its receptor has been shown to attenuate inflammation in sepsis, wound healing, and cardiovascular disease. The current study examined the effects of chronic oxytocin infusions on adipose tissue inflammation in a murine model of obesity, the leptin receptor-deficient (db\/db) mouse.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The effect of obesity on oxytocin receptor protein and mRNA expression in adipose tissue was evaluated by Western blotting and real-time polymerase chain reaction. Mice were implanted with osmotic minipumps filled with oxytocin or vehicle for 8\u2009weeks. At study endpoint adipose tissue inflammation was assessed by measurement of cytokine and adipokine mRNA tissue levels, adipocyte size and macrophage infiltration via histopathology, and plasma levels of adiponectin and serum amyloid A as markers of systemic inflammation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The expression of adipose tissue oxytocin receptor was increased in obese db\/db mice compared to lean controls. In adipose tissue oxytocin infusion reduced adipocyte size, macrophage infiltration, IL-6 and TNF\u03b1 mRNA expression, and increased the expression of the anti-inflammatory adipokine, adiponectin. In plasma, oxytocin infusion reduced the level of serum amyloid A, a marker of systemic inflammation, and increased circulating adiponectin.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In an animal model of obesity and diabetes chronic oxytocin treatment led to a reduction in visceral adipose tissue inflammation and plasma markers of systemic inflammation, which may play a role in disease progression.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12944-020-01364-x","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T16:04:55Z","timestamp":1597939495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Oxytocin reduces adipose tissue inflammation in obese mice"],"prefix":"10.1186","volume":"19","author":[{"given":"Angela","family":"Szeto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Cecati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-0822","authenticated-orcid":false,"given":"Armando J.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2337\/diabetes.52.8.2097","volume":"52","author":"G Engstrom","year":"2003","unstructured":"Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52:2097\u2013101.","journal-title":"Diabetes"},{"key":"1364_CR2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983;67:968\u201377.","journal-title":"Circulation"},{"key":"1364_CR3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1042\/BST0331049","volume":"33","author":"SW Coppack","year":"2005","unstructured":"Coppack SW. Adipose tissue changes in obesity. Biochem Soc Trans. 2005;33:1049\u201352.","journal-title":"Biochem Soc Trans"},{"key":"1364_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-245-8_1","volume":"456","author":"G Fruhbeck","year":"2008","unstructured":"Fruhbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol. 2008;456:1\u201322.","journal-title":"Methods Mol Biol"},{"key":"1364_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","volume":"15","author":"N Kloting","year":"2014","unstructured":"Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277\u201387.","journal-title":"Rev Endocr Metab Disord"},{"key":"1364_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1476-511X-10-198","volume":"10","author":"MM Altintas","year":"2011","unstructured":"Altintas MM, Rossetti MA, Nayer B, Puig A, Zagallo P, Ortega LM, et al. Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis. 2011;10:198.","journal-title":"Lipids Health Dis"},{"key":"1364_CR7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.psyneuen.2003.10.003","volume":"29","author":"CE Detillion","year":"2004","unstructured":"Detillion CE, Craft TK, Glasper ER, Prendergast BJ, DeVries AC. Social facilitation of wound healing. Psychoneuroendocrinology. 2004;29:1004\u201311.","journal-title":"Psychoneuroendocrinology"},{"key":"1364_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jss.2005.01.021","volume":"126","author":"SO Iseri","year":"2005","unstructured":"Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res. 2005;126:73\u201381.","journal-title":"J Surg Res"},{"key":"1364_CR9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0196-9781(01)00469-7","volume":"22","author":"M Petersson","year":"2001","unstructured":"Petersson M, Wiberg U, Lundeberg T, Uvnas-Moberg K. Oxytocin decreases carrageenan induced inflammation in rats. Peptides. 2001;22:1479\u201384.","journal-title":"Peptides"},{"key":"1364_CR10","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1152\/ajpendo.00346.2016","volume":"312","author":"A Szeto","year":"2017","unstructured":"Szeto A, Sun-Suslow N, Mendez AJ, Hernandez RI, Wagner KV, McCabe PM. Regulation of the macrophage oxytocin receptor in response to inflammation. Am J Physiol Endocrinol Metab. 2017;312:E183\u2013e189.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1364_CR11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PSY.0b013e3181d74c48","volume":"72","author":"DA Nation","year":"2010","unstructured":"Nation DA, Szeto A, Mendez AJ, Brooks LG, Zaias J, Herderick EE, et al. Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE\u2212\/\u2212 mice. Psychosom Med. 2010;72:376\u201382.","journal-title":"Psychosom Med"},{"key":"1364_CR12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.psyneuen.2012.08.009","volume":"38","author":"A Szeto","year":"2013","unstructured":"Szeto A, Rossetti MA, Mendez AJ, Noller CM, Herderick EE, Gonzales JA, et al. Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe heritable Hyperlipidemic rabbits. Psychoneuroendocrinology. 2013;38:685\u201393.","journal-title":"Psychoneuroendocrinology"},{"key":"1364_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jne.12268","volume":"27","author":"KJ Yi","year":"2015","unstructured":"Yi KJ, So KH, Hata Y, Suzuki Y, Kato D, Watanabe K, et al. The regulation of oxytocin receptor gene expression during adipogenesis. J Neuroendocrinol. 2015;27:335\u201342.","journal-title":"J Neuroendocrinol"},{"key":"1364_CR14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/WNR.0b013e3283021ca9","volume":"19","author":"Y Takayanagi","year":"2008","unstructured":"Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport. 2008;19:951\u20135.","journal-title":"Neuroreport"},{"key":"1364_CR15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/oby.2009.12","volume":"17","author":"C Camerino","year":"2009","unstructured":"Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring). 2009;17:980\u20134.","journal-title":"Obesity (Silver Spring)"},{"key":"1364_CR16","doi-asserted-by":"crossref","first-page":"R431","DOI":"10.1152\/ajpregu.00441.2014","volume":"308","author":"JE Blevins","year":"2015","unstructured":"Blevins JE, Graham JL, Morton GJ, Bales KL, Schwartz MW, Baskin DG, et al. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 2015;308:R431\u20138.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1364_CR17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025565","volume":"6","author":"N Deblon","year":"2011","unstructured":"Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One. 2011;6:e25565.","journal-title":"PLoS One"},{"key":"1364_CR18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.18632\/aging.100408","volume":"3","author":"Y Maejima","year":"2011","unstructured":"Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY). 2011;3:1169\u201377.","journal-title":"Aging (Albany NY)"},{"key":"1364_CR19","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1152\/ajpendo.00296.2011","volume":"302","author":"GJ Morton","year":"2012","unstructured":"Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab. 2012;302:E134\u201344.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1364_CR20","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wu C, Chen Q, Chen X, Xu Z, Wu J, et al. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One. 2013;8:e61477.","journal-title":"PLoS One"},{"key":"1364_CR21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1210\/en.2014-1718","volume":"156","author":"E Plante","year":"2015","unstructured":"Plante E, Menaouar A, Danalache BA, Yip D, Broderick TL, Chiasson JL, et al. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db\/db mice. Endocrinology. 2015;156:1416\u201328.","journal-title":"Endocrinology"},{"key":"1364_CR22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821\u201330.","journal-title":"J Clin Invest"},{"key":"1364_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1097-0185(19990415)257:2<64::AID-AR7>3.0.CO;2-G","volume":"257","author":"KA Augustine","year":"1999","unstructured":"Augustine KA, Rossi RM. Rodent mutant models of obesity and their correlations to human obesity. Anat Rec. 1999;257:64\u201372.","journal-title":"Anat Rec"},{"key":"1364_CR24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1258\/la.2007.006067","volume":"42","author":"J Speakman","year":"2008","unstructured":"Speakman J, Hambly C, Mitchell S, Kr\u00f3l E. The contribution of animal models to the study of obesity. Lab Anim. 2008;42:413\u201332.","journal-title":"Lab Anim"},{"key":"1364_CR25","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41366-019-0363-7","volume":"43","author":"JR Speakman","year":"2019","unstructured":"Speakman JR. Use of high-fat diets to study rodent obesity as a model of human obesity. Int J Obes (Lond). 2019;43:1491\u20132.","journal-title":"Int J Obes (Lond)"},{"key":"1364_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13273-010-0021-6","volume":"6","author":"S-e Lee","year":"2010","unstructured":"Lee S-e, I-s J, J-s P, Lee J-H, Lee S-Y, S-y B, et al. Systemic immunity of obese-diabetes model (db\/db) mice. Mol Cellular Toxicol. 2010;6:143\u20139.","journal-title":"Mol Cellular Toxicol"},{"key":"1364_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/clin.1995.1052","volume":"75","author":"T Yamakawa","year":"1995","unstructured":"Yamakawa T, Tanaka S-I, Yamakawa Y, Kiuchi Y, Isoda F, Kawamoto S, et al. Augmented production of tumor necrosis factor-\u03b1 in obese mice. Clin Immunol Immunopathol. 1995;75:51\u20136.","journal-title":"Clin Immunol Immunopathol"},{"key":"1364_CR28","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.3892\/mmr.2017.6518","volume":"15","author":"SM An","year":"2017","unstructured":"An SM, Kim SS, Kim J, Park MN, Lee JE, Cho SK, et al. Expression of reproductive hormone receptors and contractionassociated genes in porcine uterus during the estrous cycle. Mol Med Rep. 2017;15:4176\u201384.","journal-title":"Mol Med Rep"},{"key":"1364_CR29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"1364_CR30","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1194\/jlr.D023788","volume":"53","author":"M Galarraga","year":"2012","unstructured":"Galarraga M, Campion J, Munoz-Barrutia A, Boque N, Moreno H, Martinez JA, et al. Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections. J Lipid Res. 2012;53:2791\u20136.","journal-title":"J Lipid Res"},{"key":"1364_CR31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"1364_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/1-59259-231-7:097","volume-title":"Adipose tissue protocols","author":"C Holm","year":"2001","unstructured":"Holm C, Olivecrona G, Ottosson M. Assays of Lipolytic enzymes. In: Ailhaud G, editor. Adipose tissue protocols. Totowa: Springer New York; 2001. p. 97\u2013119."},{"key":"1364_CR33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/molehr\/3.11.957","volume":"3","author":"T Kimura","year":"1997","unstructured":"Kimura T, Makino Y, Bathgate R, Ivell R, Nobunaga T, Kubota Y, et al. The role of N-terminal glycosylation in the human oxytocin receptor. Mol Hum Reprod. 1997;3:957\u201363.","journal-title":"Mol Hum Reprod"},{"key":"1364_CR34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","volume":"36","author":"J Mauer","year":"2015","unstructured":"Mauer J, Denson JL, Br\u00fcning JC. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol. 2015;36:92\u2013101.","journal-title":"Trends Immunol"},{"key":"1364_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2018","unstructured":"Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119:105\u201310.","journal-title":"J Cell Biochem"},{"key":"1364_CR36","doi-asserted-by":"crossref","first-page":"139239","DOI":"10.1155\/2013\/139239","volume":"2013","author":"K Makki","year":"2013","unstructured":"Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN inflammation. 2013;2013:139239.","journal-title":"ISRN inflammation"},{"key":"1364_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cytogfr.2015.12.010","volume":"30","author":"M De Buck","year":"2016","unstructured":"De Buck M, Gouwy M, Wang JM, Van Snick J, Proost P, Struyf S, et al. The cytokine-serum amyloid A-chemokine network. Cytokine Growth Factor Rev. 2016;30:55\u201369.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1364_CR38","volume":"9","author":"LJ den Hartigh","year":"2014","unstructured":"den Hartigh LJ, Wang S, Goodspeed L, Ding Y, Averill M, Subramanian S, et al. Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice. PLoS One. 2014;9:e108564.","journal-title":"PLoS One"},{"key":"1364_CR39","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1152\/ajpendo.00110.2003","volume":"285","author":"JM Bruun","year":"2003","unstructured":"Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285:E527\u201333.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1364_CR40","doi-asserted-by":"crossref","first-page":"658913","DOI":"10.1155\/2014\/658913","volume":"2014","author":"E Nigro","year":"2014","unstructured":"Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014;2014:658913.","journal-title":"Biomed Res Int"},{"key":"1364_CR41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24\u201330.","journal-title":"Clin Chim Acta"},{"key":"1364_CR42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1055\/s-0034-1395677","volume":"47","author":"L Gajdosechova","year":"2015","unstructured":"Gajdosechova L, Krskova K, Olszanecki R, Zorad S. Differential regulation of oxytocin receptor in various adipose tissue depots and skeletal muscle types in obese Zucker rats. Horm Metab Res. 2015;47:600\u20134.","journal-title":"Horm Metab Res"},{"key":"1364_CR43","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/en.2014-1466","volume":"155","author":"J Altirriba","year":"2014","unstructured":"Altirriba J, Poher AL, Caillon A, Arsenijevic D, Veyrat-Durebex C, Lyautey J, et al. Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes. Endocrinology. 2014;155:4189\u2013201.","journal-title":"Endocrinology"},{"key":"1364_CR44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.peptides.2013.04.010","volume":"45","author":"VE Chaves","year":"2013","unstructured":"Chaves VE, Tilelli CQ, Brito NA, Brito MN. Role of oxytocin in energy metabolism. Peptides. 2013;45:9\u201314.","journal-title":"Peptides"},{"key":"1364_CR45","doi-asserted-by":"crossref","first-page":"21416","DOI":"10.1016\/S0021-9258(18)54654-8","volume":"266","author":"E Kojro","year":"1991","unstructured":"Kojro E, Hackenberg M, Zsigo J, Fahrenholz F. Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist. J Biol Chem. 1991;266:21416\u201321.","journal-title":"J Biol Chem"},{"key":"1364_CR46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbamem.2006.09.008","volume":"1768","author":"C Dong","year":"2007","unstructured":"Dong C, Filipeanu CM, Duvernay MT, Wu G. Regulation of G protein-coupled receptor export trafficking. Biochim Biophys Acta Biomembr. 2007;1768:853\u201370.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"1364_CR47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/acsptsci.0c00016","volume":"3","author":"CK Goth","year":"2020","unstructured":"Goth CK, Pet\u00e4j\u00e4-Repo UE, Rosenkilde MM. G protein-coupled receptors in the sweet spot: glycosylation and other post-translational modifications. ACS Pharmacol Transl Sci. 2020;3:237\u201345.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1364_CR48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/mp.2012.103","volume":"18","author":"W Romero-Fernandez","year":"2013","unstructured":"Romero-Fernandez W, Borroto-Escuela DO, Agnati LF, Fuxe K. Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor\u2013receptor interactions. Mol Psychiatry. 2013;18:849\u201350.","journal-title":"Mol Psychiatry"},{"key":"1364_CR49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/me.2002-0222","volume":"17","author":"S Terrillon","year":"2003","unstructured":"Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol. 2003;17:677\u201391.","journal-title":"Mol Endocrinol"},{"key":"1364_CR50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cellsig.2011.09.019","volume":"24","author":"PK Wrzal","year":"2012","unstructured":"Wrzal PK, Goupil E, Laporte SA, H\u00e9bert TE, Zingg HH. Functional interactions between the oxytocin receptor and the \u03b22-adrenergic receptor: implications for ERK1\/2 activation in human myometrial cells. Cell Signal. 2012;24:333\u201341.","journal-title":"Cell Signal"},{"key":"1364_CR51","doi-asserted-by":"crossref","first-page":"R360","DOI":"10.1152\/ajpregu.00344.2014","volume":"308","author":"Y Iwasaki","year":"2015","unstructured":"Iwasaki Y, Maejima Y, Suyama S, Yoshida M, Arai T, Katsurada K, et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol. 2015;308:R360\u20139.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1364_CR52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1677\/jme.0.0300109","volume":"30","author":"T Kimura","year":"2003","unstructured":"Kimura T, Saji F, Nishimori K, Ogita K, Nakamura H, Koyama M, et al. Molecular regulation of the oxytocin receptor in peripheral organs. J Mol Endocrinol. 2003;30:109\u201315.","journal-title":"J Mol Endocrinol"},{"key":"1364_CR53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diabet.2017.10.004","volume":"44","author":"S Garrido-Urbani","year":"2018","unstructured":"Garrido-Urbani S, Deblon N, Poher AL, Caillon A, Ropraz P, Rohner-Jeanrenaud F, et al. Inhibitory role of oxytocin on TNF\u03b1 expression assessed in vitro and in vivo. Diabetes Metab. 2018;44:292\u20135.","journal-title":"Diabetes Metab"},{"key":"1364_CR54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4158\/EP151192.RA","volume":"22","author":"E Barengolts","year":"2016","unstructured":"Barengolts E. Oxytocin - an emerging treatment for obesity and dysglycemia: review of randomized controlled trials and cohort studies. Endocr Pract. 2016;22:885\u201394.","journal-title":"Endocr Pract"},{"key":"1364_CR55","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.physbeh.2015.05.023","volume":"152","author":"JE Blevins","year":"2015","unstructured":"Blevins JE, Baskin DG. Translational and therapeutic potential of oxytocin as an anti-obesity strategy: insights from rodents, nonhuman primates and humans. Physiol Behav. 2015;152:438\u201349.","journal-title":"Physiol Behav"},{"key":"1364_CR56","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.ddmec.2013.05.006","volume":"10","author":"D Cai","year":"2013","unstructured":"Cai D, Purkayastha S. A new horizon: oxytocin as a novel therapeutic option for obesity and diabetes. Drug Discovery Today: Disease Mechanisms. 2013;10:e63\u20138.","journal-title":"Drug Discovery Today: Disease Mechanisms"},{"key":"1364_CR57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MED.0000000000000351","volume":"24","author":"PK Olszewski","year":"2017","unstructured":"Olszewski PK, Klockars A, Levine AS. Oxytocin and potential benefits for obesity treatment. Curr Opin Endocrinol Diabetes Obes. 2017;24:320\u20135.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1364_CR58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","volume":"13","author":"MY Donath","year":"2014","unstructured":"Donath MY. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov. 2014;13:465\u201376.","journal-title":"Nat Rev Drug Discov"},{"key":"1364_CR59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc12-0702","volume":"36","author":"X Wang","year":"2013","unstructured":"Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36:166\u201375.","journal-title":"Diabetes Care"},{"key":"1364_CR60","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.peptides.2006.03.029","volume":"27","author":"NK Biyikli","year":"2006","unstructured":"Biyikli NK, Tugtepe H, Sener G, Velioglu-Ogunc A, Cetinel S, Midillioglu S, et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides. 2006;27:2249\u201357.","journal-title":"Peptides"},{"key":"1364_CR61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.peptides.2004.10.005","volume":"26","author":"SO Iseri","year":"2005","unstructured":"Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides. 2005;26:483\u201391.","journal-title":"Peptides"},{"key":"1364_CR62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbagen.2015.10.025","volume":"1860","author":"BY Klein","year":"2016","unstructured":"Klein BY, Tamir H, Hirschberg DL, Ludwig RJ, Glickstein SB, Myers MM, et al. Oxytocin opposes effects of bacterial endotoxin on ER-stress signaling in Caco2BB gut cells. Biochim Biophys Acta Gen Subj. 2016;1860:402\u201311.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1364_CR63","doi-asserted-by":"crossref","first-page":"G848","DOI":"10.1152\/ajpgi.00176.2014","volume":"307","author":"MG Welch","year":"2014","unstructured":"Welch MG, Margolis KG, Li Z, Gershon MD. Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice. Am J Physiol Gastrointest Liver Physiol. 2014;307:G848\u201362.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1364_CR64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psyneuen.2017.07.486","volume":"85","author":"C Baskaran","year":"2017","unstructured":"Baskaran C, Plessow F, Silva L, Asanza E, Marengi D, Eddy KT, et al. Oxytocin secretion is pulsatile in men and is related to social-emotional functioning. Psychoneuroendocrinology. 2017;85:28\u201334.","journal-title":"Psychoneuroendocrinology"},{"key":"1364_CR65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-662-12587-8_13","volume-title":"Neurosecretion \u2014 The Final Neuroendocrine Pathway: VI International Symposium on Neurosecretion, London 1973","author":"DW Lincoln","year":"1974","unstructured":"Lincoln DW. Dynamics of oxytocin secretion. In: Knowles F, Vollrath L, editors. Neurosecretion \u2014 The Final Neuroendocrine Pathway: VI International Symposium on Neurosecretion, London 1973. Berlin: Springer Berlin Heidelberg; 1974. p. 129\u201333."},{"key":"1364_CR66","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.ddmec.2013.05.006","volume":"10","author":"D Cai","year":"2013","unstructured":"Cai D, Purkayastha S. A new horizon: oxytocin as a novel therapeutic option for obesity and diabetes. Drug Discov Today Dis Mech. 2013;10:e63\u20138.","journal-title":"Drug Discov Today Dis Mech"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-020-01364-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:18:35Z","timestamp":1629415115000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01364-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01364-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Procedures for the care, use and euthanasia of experimental animals followed the protocols and regulations set forth by the Animal Care and Use Committee of the University of Miami and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}